Author:
Kim Jooran S.,Nafziger Anne N.,Tsunoda Shirley M.,Choo Edna F.,Streetman Daniel S.,Kashuba Angela D. M.,Kulawy Robert W.,Beck Debra J.,Rocci Mario L.,Wilkinson Grant R.,Greenblatt David J.,Bertino Joseph S.
Subject
Pharmacology (medical),Pharmacology
Reference38 articles.
1. Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues;Tucker;Xenobiotica,1998
2. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes;Streetman;Pharmacogenetics,2000
3. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients;Thummel;J Pharmacol Exp Ther,1994
4. Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation;Thummel;J Pharmacol Exp Ther,1994
5. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism;Thummel;Clin Pharmacol Ther,1996
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献